SAN DIEGO — Treatment options for food allergies are expanding, but interpreting research findings for individualized clinical care is tricky. That theme emerged at the American Academy of Allergy, ...
SAN DIEGO -- Omalizumab (Xolair) injections outperformed oral immunotherapy (OIT) in increasing tolerance among children with multi-food allergy, largely because many patients couldn't tolerate OIT, ...
Please provide your email address to receive an email when new articles are posted on . Patients received omalizumab with placebo oral immunotherapy or vice versa. 88% of the omalizumab group and 51% ...
A study led by Johns Hopkins Children's Center shows omalizumab—an injectable, Food and Drug Administration-approved medication for treating asthma and other allergic conditions—substantially reduced ...
INCHEON, South Korea, Dec. 3, 2025 /PRNewswire/ -- Celltrion, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new presentation of OMLYCLO® (omalizumab-igec), the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results